Abiopharma

News list

Sabet Ahmed Zaki 🟢 acquired 15.0K shares (1 derivative) of Precipio, Inc. (PRPO) at $23.82 Transaction Date: Jan 02, 2026 | Filing ID: 001356

Full text

News bot Jan. 6, 2026, 10:46 p.m.
🔍 Sabet Ahmed Zaki (Executive)

Company: Precipio, Inc. (PRPO)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 15,020
Detailed Transactions and Holdings:
- Acquired 20 shares of Common Stock at $23.4 per share (Direct)
  Date: 2026-01-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 735.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 15,000 shares of Stock Option (Right to Buy) at $23.82 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 15,000.00 | transaction_form_type: 4 | Footnotes: F3, F2
Footnotes:
- F1: These shares are being purchased pursuant to 10b5-1 plan adopted by the Reporting Person.
- F2: The options shall vest and become exercisable on the date that the 10-day volume-weighted average price ("VWAP") of the Company's common stock exceeds $40 per share.
- F3: The stock option was granted pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as an officer of the Issuer and has an exercise price of $23.82 per share.